These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17082800)

  • 21. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
    Barad DH
    Obstet Gynecol; 2005 Jul; 106(1):196-7; author reply 197. PubMed ID: 15994648
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pregnancy results in in vitro fertilization in one case of luteinized-unruptured-follicle syndrome].
    Letouzey V; Reyftmann L; Hamamah S; Hédon B
    Gynecol Obstet Fertil; 2008 Jan; 36(1):60-2. PubMed ID: 18248842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment.
    Ng EH
    Gynecol Endocrinol; 2009 Jan; 25(1):2-7. PubMed ID: 19165656
    [No Abstract]   [Full Text] [Related]  

  • 24. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pituitary down-regulation and ovulation stimulation with gradually increased gonadotropin in controlled ovarian hyperstimulation].
    Zhu L; Song YL; Cui YG; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):361-3. PubMed ID: 17425993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ascites ultrafiltration and concentration-reinfusion in severe ovarian hyperstimulation syndrome.
    Liangfei A; Liangbin X; Wangming X; Jing Y
    Br J Hosp Med (Lond); 2011 Mar; 72(3):170-1. PubMed ID: 21475099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman.
    Wiygul JB; Lallas C; Silverstein A; Polascik TJ
    Urology; 2006 May; 67(5):1085.e5-6. PubMed ID: 16698384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.
    Selman H; Brusco GF; Fiorini F; Barnocchi N; Mariani M; El-Danasouri I
    Fertil Steril; 2009 Apr; 91(4 Suppl):1611-3. PubMed ID: 19200960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carotid thrombosis after in vitro fertilization: a relatively new thrombotic complication in women.
    Martí E; Santamaría A; Mateo J; Tolosa A; Querol L; Viscasillas P; Fontcuberta J
    Br J Haematol; 2008 Jun; 141(6):897-9. PubMed ID: 18355379
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ovarian hyperstimulation syndrome].
    Geva E; Lessing JB; Amit A
    Harefuah; 1995 Feb; 128(4):237-42. PubMed ID: 7744337
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ovarian hyperstimulation syndrome. Diagnosis and prevention are extremely important].
    Nylund L; Carlström K; Gustafson O
    Lakartidningen; 1993 Mar; 90(10):915-7. PubMed ID: 8459733
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of luteinizing hormone in assisted reproduction: a review.
    Weghofer A; Schnepf S; Barad D; Gleicher N
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):253-7. PubMed ID: 17495642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization.
    Huddleston HG; Racowsky C; Jackson KV; Fox JH; Ginsburg ES
    Fertil Steril; 2008 Oct; 90(4):1259-62. PubMed ID: 18163999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and obstetric outcome of ovarian hyperstimulation syndrome.
    Zareen N
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):86-90. PubMed ID: 18454892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine and antiphospholipid antibodies in a woman undergoing ovarian follicular stimulation: prospective clinical and laboratory evaluation.
    Grandone E; Vecchione G; Colaizzo D; Cappucci F; Margaglione M
    Am J Obstet Gynecol; 2004 Jul; 191(1):370-1. PubMed ID: 15295397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous ovarian hyperstimulation syndrome.
    Kasum M; Oresković S; Jezek D
    Coll Antropol; 2013 Jun; 37(2):653-6. PubMed ID: 23941020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical Ovarian Hyperstimulation Syndrome After In Vitro Fertilization Treatment in a Renal Transplant Recipient: A Case Report.
    Zheng HH; Song Y; Wu JY
    Transplant Proc; 2016; 48(1):267-70. PubMed ID: 26915882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
    Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
    Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.